Update on the genetic basis of drug hypersensitivity reactions

Jurado-Escobar, R; Perkins, JR; García-Martín, E; Isidoro-García, M; Doña, I; Perkins, JR; Torres, MJ; Perkins, JR; Cornejo-García, JA.
J. investig. allergol. clin. immunol ; 27(6): 336-345, 2017.
Artículo en Inglés | IBECS (España) | ID: ibc-169169

Documentos relacionados

  1. Rapid Detection of Prunus Necrotic Ringspot Virus by Reverse Transcription-cross-priming Amplification Coupled with Nucleic Acid Test Strip Cassette.
  2. Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells.
  3. Novel Cre-Expressing Mouse Strains Permitting to Selectively Track and Edit Type 1 Conventional Dendritic Cells Facilitate Disentangling Their Complexity <i>in vivo</i>.
  4. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8&#945;<sup>+</sup> dendritic cells.
  5. Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice.
  6. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance.
  7. Polymorphisms in eicosanoid-related biosynthesis enzymes associated with acute urticaria/angioedema induced by nonsteroidal anti-inflammatory drug hypersensitivity.
  8. Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation.
  9. Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions.
  10. [Pharmacogenomics of severe drug hypersensitivity reactions--from bench to bedside].